Results 1 to 10 of about 8,430 (140)

Insights on the spatial distribution of the Pseudomonas aeruginosa secondary metabolites under swarming motility-inducing conditions using mass spectrometry imaging [PDF]

open access: yesMicrobiology Spectrum
Pseudomonas aeruginosa exhibits a variety of motility types, including twitching, swimming, and swarming motility. The latter is typically associated with growth on semi-solid surfaces (e.g., 0.4% to 0.5% agar), the formation of extending tendrils, and ...
Joenisse M. Rosado-Rosa   +3 more
doaj   +2 more sources

Enhanced anaerobic synthesis of rhamnolipids and emulsification of crude oil by genetically engineered Pseudomonas aeruginosa strains [PDF]

open access: yesMicrobial Cell Factories
Background Pseudomonas aeruginosa is a facultative anaerobic bacterium widely distributed in oil reservoirs. Efficient production of rhamnolipids by P. aeruginosa in anoxic environments of oil reservoirs contributes to oil displacement.
Feng Zhao, Yuting Wu, Lu Liu
doaj   +2 more sources

Attenuated Strains of Pseudomonas aeruginosa: A Promising Cell Factory for Rhamnolipid Production [PDF]

open access: yesMicrobial Biotechnology
Biodegradable compounds like rhamnolipids provide an environmentally friendly alternative to petroleum‐based surfactants. Pseudomonas aeruginosa is the most proficient producer of rhamnolipids.
Parvathy V. Das   +3 more
doaj   +2 more sources

Antifungal activity and mycotoxin-inhibiting potential of amphisin and rhamnolipids from Pseudomonas strains [PDF]

open access: yesScientific Reports
Biosurfactants, due to their amphiphilic properties, are widely used across a broad spectrum of industries. In this paper, we describe experiments conducted to determine the antagonistic activity of amphisin and rhamnolipids against fungal plant ...
Dominika Ciurko   +4 more
doaj   +2 more sources

Evaluation of the Emulsification Properties of Marine-Derived Rhamnolipids for Encapsulation: A Comparison with Commercial Surfactants [PDF]

open access: yesBiomolecules
Rhamnolipids are a class of glycolipids known for their surface and emulsifying activity. These molecules, produced by a few Gram-negative genera, mostly Pseudomonas, offer natural alternatives to synthetic surfactants in different industrial fields ...
Sara Gorrieri   +10 more
doaj   +2 more sources

Heterologous rhamnolipid biosynthesis by P. putida KT2440—ACP dependency and the role of fatty acid metabolism [PDF]

open access: yesApplied and Environmental Microbiology
Rhamnolipids are glycolipids and, as such, biosurfactants with high surface activity, good biodegradability, low toxicity, and thus manifold applications.
Melanie Filbig   +8 more
doaj   +2 more sources

Antiviral Activity of Rhamnolipids Nano-Micelles Against Rhinoviruses—In Silico Docking, Molecular Dynamic Analysis and In-Vitro Studies [PDF]

open access: yesCurrent Issues in Molecular Biology
Hospital-acquired infections (HAIs) previously focused mainly on multidrug-resistant (MDR) bacteria, with less attention on viruses. The COVID-19 pandemic highlighted the importance of controlling viral infections. Human rhinoviruses (HRVs) are among the
Lila Touabi   +4 more
doaj   +2 more sources

Rhamnolipids bio-production and miscellaneous applications towards green technologies: a literature review [PDF]

open access: yesPeerJ
Growing attention towards rhamnolipids (RLs) biosurfactants with antibacterial, antifungal, antivirus and antitumor potentials encourage future research in biotechnology and biomedicine fields.
Sanaa S.A. Kabeil   +8 more
doaj   +3 more sources

Emulsifying Properties of Rhamnolipids and Their In Vitro Antifungal Activity against Plant Pathogenic Fungi

open access: yesMolecules, 2022
Rhamnolipids have significant emulsifying activity and the potential to become a component of pesticide emulsifier. Rhamnolipids are usually composed of two main components: mono-rhamnolipids (Rha-C10-C10) and di-rhamnolipids (Rha2-C10-C10).
Dongmei Li   +3 more
doaj   +1 more source

Rhamnolipids Nano-Micelles as a Potential Hand Sanitizer

open access: yesAntibiotics, 2021
COVID-19 is a pandemic disease caused by the SARS-CoV-2, which continues to cause global health and economic problems since emerging in China in late 2019. Until now, there are no standard antiviral treatments.
Marwa Reda Bakkar   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy